Human cytomegalovirus-induced host cell enlargement is iron dependent

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 4 56-4, 2004, Pages

  Crowe, William E ^a   Maglova, Lilia M ^a   Ponka, Prem ^b,c   Russell, John M ^a  

^a SYRACUSE UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Cell size; Mitochondria

Indexed keywords

CALCEIN; IRON; ISONIAZID DERIVATIVE;

ARTICLE; CELL CULTURE; CELL SIZE; CHELATION; CYTOMEGALY; DEPOLARIZATION; FIBROBLAST; GRAIN; HOMEOSTASIS; HOST CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOPATHOGENIC EFFECT, VIRAL; FIBROBLASTS; HUMANS; IRON; IRON CHELATING AGENTS; LUNG; MEMBRANE POTENTIALS; MITOCHONDRIA;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 4544230826     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00511.2003     Document Type: Article

References (58)

1. Akaike T. Role of free radicals in viral pathogenesis and mutation. Rev Med Virol 11: 87-101, 2001.
2. Albrecht T, Boldogh I, Fons M, Lee CH, AbuBakar S, Russell JM, and Au WW. Cell-activation responses to cytomegalovirus infection relationship to the phasing of CMV replication and to the induction of cellular damage. Subcell Biochem 15:157-202, 1989.
3. Albrecht T, Lee CH, Speelman DJ, and Steinsland OS. Inhibition of cytomegalovirus replication by smooth-muscle relaxing agents. Proc Soc Exp Biol Med 186: 41-46, 1987.
4. Altamirano AA, Fons MP, Russell JM, Cragoe EJ Jr, and Albrecht T. Human cytomegalovirus infection increases the number of ouabain-binding sites in human fibroblasts. Virology 199: 151-159, 1994.
5. Alvarez-Leefmans FJ, Altamirano J, and Crowe WE. Use of ion-selective microelectrodes and fluorescent probes to measure cell volume. Methods Neurosci 27: 361-391, 1995.
6. Atamna H, Walter PB, and Ames BN. The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch Biochem Biophys 397: 345-353, 2002.
7. Baker E, Richardson D, Gross S, and Ponka P. Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture. Hepatologv 15: 492-501, 1992.
8. Breuer W, Epsztejn S, Millgram P, and Cabantchik IZ. Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am J Physiol Cell Physiol 268: C1354-C1361, 1995.
9. Britton RS, Leicester KL, and Bacon BR. Iron toxicity and chelation therapy. Int J Hematol 76: 219-228, 2002.
10. Cinatl J, Scholz M, Weber B, Cinatl J, Rabenau H, Markus BH, Encke A, and Doerr HW. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Transpl Immunol 3: 313-320, 1995.
11. Cinatl J Jr, Cinatl J, Rabenau H, Gumbel HO, Kornhuber B, and Doerr HW. In vitro inhibition of human cytomegalovirus replication by desferrioxamine. Antiviral Res 25: 73-77, 1994.
12. Collins TJ, Berridge MJ, Lipp P, and Bootman MD. Mitochondria are morphologically and functionally heterogeneous within cells. EMBO J 21: 1616-1627, 2002.
13. Conti C, Mastromarino P, Valenti P, Tomao P, and Orsi N. Effect of desferrioxamine B, a metal chelating agent, on rhabdovirus multiplication. Boll 1st Sieroter Milan 69: 431-436, 1990.
14. Cooper CE, Lynagh GR, Hoyes KP, Hider RC, Cammack R, and Porter JB. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase. J Biol Chem 271: 20291-20299, 1996.
15. + exchange in human fibroblasts. Am J Physiol Cell Physiol 273: C1739-C1748, 1997.
16. Crowe WE, Altamirano J, Huerto L, and Alvarez-Leefmans FJ. Volume changes in single N1E-115 neuroblastoma cells measured with a fluorescent probe. Neuroscience 69: 283-296, 1995.
17. Crowe WE, Maglova LM, Reeves AP, and Russell JM. Appearance of abundant small grain-like mitochondria in human cytomegalovirus-infected MRC-5 fibroblast (Abstract). FASEB J 18: A694, 2004.
18. Dias N and Lima N. A comparative study using a fluorescence-based and a direct-count assay to determine cytotoxicity in Tetrahymena pyriformis. Res Microbiol 153: 313-322, 2002.
19. Dickman KG, Hempson SJ, Anderson J, Lippe S, Zhao L, Burakoff R, and Shaw RD. Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 279: G757-G766, 2000.
20. Emsley J. The Elements (3rd ed.). New York: Oxford University Press, 1998.
21. Epsztejn S, Kakhlon O, Glickstein H, Breuer W, and Cabantchik I. Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem 248: 31-40, 1997.
22. Esposito BP, Epsztejn S, Breuer W, and Cabantchik ZI. A review of fluorescence methods for assessing labile iron in cells and biological fluids. Anal Biochem 304: 1-18, 2002.
23. Fleming RE and Sly WS. Mechanisms of iron accumulation in hereditary hemochromatosis. Annu Rev Physiol 64: 663-680, 2002.
24. Flemington EK. Herpesvirus lytic replication and the cell cycle: arresting new developments. J Virol 75: 4475-4481, 2001.
25. Fortunato EA, McElroy AK, Sanchez I, and Spector DH. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 8: 111-119, 2000.
26. Furman MH and Ploegh HL. Lessons from viral manipulation of protein disposal pathways. J Clin Invest 110: 875-879, 2002.
27. Furukawa T, Sakuma S, and Plotkin SA. Human cytomegalovirus infection of WI-38 cells stimulates mitochondrial DNA synthesis. Nature 262: 414-416. 1976.
28. 2+ and other metal ions. In: Handbook of Fluorescent Probes and Research Products (9th ed.), edited by Haugland RP. Eugene, OR: Molecular Probes, 2002, chapt. 20. p. 767-826.
29. Kakhlon O, Gruenbaum Y, and Cabantchik ZI. Repression of ferritin expression modulates cell responsiveness to H-ras-induced growth. Biochem Soc Trans 30: 777-780, 2002.
30. Labbé RF, Vreman HJ, and Stevenson DK. Zinc protoporphyrin: a metabolite with a mission. Clin Chem 45: 2060-2072, 1999.
31. Le NT and Richardson DR. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603: 31-46, 2002.
32. Lewis JA, Huq A, and Najarro P. Inhibition of mitochondrial function by interferon. J Biol Chem 271: 13184-13190, 1996.
33. Lin E, Graziano JH, and Freyer GA. Regulation of the 75-kDa subunit of mitochondrial complex I by iron. J Biol Chem 276: 27685-27692, 2001.
34. Liochev SL. The role of iron-sulfur clusters in in vivo hydroxyl radical production. Free Radic Res 25: 369-384, 1996.
35. - exchanger activity in human fibroblasts. Am J Physiol Cell Physiol 275: C515-C526, 1998.
36. Maglova LM, Crowe WE, and Russell JM. Perinuclear localization of Na-K-Cl-cotransporter protein after human cytomegalovirus infection. Am J Physiol Cell Physiol 286: C1324-C1334, 2004.
37. - cotransport in human fibroblasts is inhibited by cytomegalovirus infection. Am J Physiol Cell Physiol 275: C1330-C1341, 1998.
38. McCormick AL, Smith VL, Chow D, and Mocarski ES. Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol 77: 631-641, 2003.
39. Murata T, Goshima F, Daikoku T, Inagaki-Ohara K, Takakuwa H, Kalo K, and Nishiyama Y. Mitochondrial distribution and function in herpes simplex virus-infected cells. J Gen Virol 81: 401-406, 2000.
40. 2+ responses in cytomegalovirus-infected fibroblasts of human origin. Virologv 157: 259-267, 1987.
41. Nokta M, Fons MP, Eaton DC, and Albrecht T. Cytomegalovirus: sodium entry and development of cytomegaly in human fibroblasts. Virology 164: 411-419, 1988.
42. Oexle H, Gnaiger E, and Weiss G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim Biophys Acta 1413: 99-107, 1999.
43. Oshiro S, Nozawa K, Hori M, Zhang C, Hashimoto Y, Kitajima S, and Kawamura K. Modulation of iron regulatory protein-1 by various metals. Biochem Biophys Res Commun 290: 213-218, 2002.
44. Petrat F, de Groot H, and Rauen U. Determination of the chelatable iron pool of single intact cells by laser scanning microscopy. Arch Biochem Biophys 376: 74-81, 2000.
45. Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, and Di Lisa F. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76: 725-734, 1999.
46. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, and O'Halloran TV. Undetectable intracellular free copper: the requirement of a copper chaperone for Superoxide dismutase. Science 284: 805-808, 1999.
47. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 12: 417-427, 1992.
48. Richardson DR, Hefter GT, May PM, Webb J, and Baker E. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II). Biol Met 2: 161-167, 1989.
49. Richardson DR and Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1331: 1-40, 1997.
50. Romeo AM, Christen L, Niles EG, and Kosman DJ. Intracellular chelation of iron by bipyridyl inhibits DNA virus replication: ribonucleotide reductase maturation as a probe of intracellular iron pools. J Biol Chem 276: 24301-24308, 2001.
51. Tugizov S, Maidji E, Xiao J, and Pereira L. An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol 73: 8677-8688, 1999.
52. Vahdati-Ben Arieh S, Laham N, Schechter C, Yewdell JW, Coligan JE, and Ehrlich R. A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. Blood 101: 2858-2864, 2003.
53. Van Asbeck BS, Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, and Marx JJ. Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol 20: 141-147, 2001.
54. Vásquez-Vivar J, Kalyanaraman B, and Kennedy MC. Mitochondrial aconitase is a source of hydroxyl radical: an electron spin resonance investigation. J Biol Chem 275: 14064-14069, 2000.
55. Vitolo ML, Clare BW, Hefter GT, and Webb J. Chemical studies of pyridoxal isonicotinoyl hydrazone relevant to its clinical evaluation. Birth Defects Orig Artic Ser 23: 71-79, 1988.
56. Ying W, Han SK, Miller JW, and Swanson RA. Acidosis potentiates oxidative neuronal death by multiple mechanisms. J Neurochem 73: 1549-1556, 1999.
57. Zhu H, Cong JP, Mamtora G, Gingeras T, and Shenk T. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci USA 95: 14470-14475, 1998.
58. Zhu H, Cong JP, Yu D, Bresnahan WA, and Shenk TE. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA 99: 3932-3937, 2002.